138 related articles for article (PubMed ID: 9871564)
1. 1-[omega-(4-arylpiperazin-1-yl)alkyl]-3-diphenylmethylene-2,5- pyrrolidinediones as 5-HT1A receptor ligands: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Sanz AM; Orensanz L
Bioorg Med Chem Lett; 1998 Mar; 8(6):581-6. PubMed ID: 9871564
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
[TBL] [Abstract][Full Text] [Related]
3. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.
Perrone R; Berardi F; Colabufo NA; Leopoldo M; Lacivita E; Tortorella V; Leonardi A; Poggesi E; Testa R
J Med Chem; 2001 Dec; 44(25):4431-42. PubMed ID: 11728188
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationships of a new model of arylpiperazines. 3.1 2-[omega-(4-arylpiperazin-1-yl)alkyl]perhydropyrrolo- [1,2-c]imidazoles and -perhydroimidazo[1,5-a]pyridines: study of the influence of the terminal amide fragment on 5-HT1A affinity/selectivity.
López-Rodríguez ML; Morcillo MJ; Fernández E; Porras E; Murcia M; Sanz AM; Orensanz L
J Med Chem; 1997 Aug; 40(16):2653-6. PubMed ID: 9258372
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of a new model of arylpiperazines. 1. 2-[[4-(o-methoxyphenyl)piperazin-1-yl]methyl]-1, 3-dioxoperhydroimidazo[1,5-alpha]pyridine: a selective 5-HT1A receptor agonist.
López-Rodríguez ML; Rosado ML; Benhamú B; Morcillo MJ; Sanz AM; Orensanz L; Beneitez ME; Fuentes JA; Manzanares J
J Med Chem; 1996 Oct; 39(22):4439-50. PubMed ID: 8893838
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel 5-substituted 3-amino-3,4-dihydro-2H-1-benzopyran derivatives and their interactions with the 5-HT1A receptor.
Hammarberg E; Nordvall G; Leideborg R; Nylöf M; Hanson S; Johansson L; Thorberg SO; Tolf BR; Jerning E; Svantesson GT; Mohell N; Ahlgren C; Westlind-Danielsson A; Csöregh I; Johansson R
J Med Chem; 2000 Jul; 43(15):2837-50. PubMed ID: 10956192
[TBL] [Abstract][Full Text] [Related]
7. 2-aminotetralin-derived substituted benzamides with mixed dopamine D2, D3, and serotonin 5-HT1A receptor binding properties: a novel class of potential atypical antipsychotic agents.
Homan EJ; Copinga S; Elfström L; van der Veen T; Hallema JP; Mohell N; Unelius L; Johansson R; Wikström HV; Grol CJ
Bioorg Med Chem; 1998 Nov; 6(11):2111-26. PubMed ID: 9881101
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship studies of CNS agents, Part 32: Effect of structural modifications in 1-arylpiperazine derivatives on alpha(1) -adrenoreceptor affinity.
Mokrosz MJ; Paluchowska MH; Charakchieva-Minol S; Bień A
Arch Pharm (Weinheim); 1997 Jun; 330(6):177-80. PubMed ID: 9264242
[TBL] [Abstract][Full Text] [Related]
9. N-Substituted (2,3-dihydro-1,4-benzodioxin-2-yl)methylamine derivatives as D(2) antagonists/5-HT(1A) partial agonists with potential as atypical antipsychotic agents.
Birch AM; Bradley PA; Gill JC; Kerrigan F; Needham PL
J Med Chem; 1999 Aug; 42(17):3342-55. PubMed ID: 10464021
[TBL] [Abstract][Full Text] [Related]
10. 1-aryl-4-[(5-methoxy-1,2,3, 4-tetrahydronaphthalen-1-yl)alkyl]piperazines and their analogues: influence of the stereochemistry of the tetrahydronaphthalen-1-yl nucleus on 5-HT1A receptor affinity and selectivity versus alpha1 and D2 receptors. 5.
Perrone R; Berardi F; Colabufo NA; Leopoldo M; Tortorella V
J Med Chem; 1999 Feb; 42(3):490-6. PubMed ID: 9986719
[TBL] [Abstract][Full Text] [Related]
11. WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
Bolognesi ML; Budriesi R; Cavalli A; Chiarini A; Gotti R; Leonardi A; Minarini A; Poggesi E; Recanatini M; Rosini M; Tumiatti V; Melchiorre C
J Med Chem; 1999 Oct; 42(20):4214-24. PubMed ID: 10514291
[TBL] [Abstract][Full Text] [Related]
12. Orally active benzamide antipsychotic agents with affinity for dopamine D2, serotonin 5-HT1A, and adrenergic alpha1 receptors.
Reitz AB; Baxter EW; Codd EE; Davis CB; Jordan AD; Maryanoff BE; Maryanoff CA; McDonnell ME; Powell ET; Renzi MJ; Schott MR; Scott MK; Shank RP; Vaught JL
J Med Chem; 1998 Jun; 41(12):1997-2009. PubMed ID: 9622541
[TBL] [Abstract][Full Text] [Related]
13. Analogues of the potential antipsychotic agent 1192U90: amide modifications.
Navas F; Tang FL; Schaller LT; Norman MH
Bioorg Med Chem; 1998 Jun; 6(6):811-23. PubMed ID: 9681147
[TBL] [Abstract][Full Text] [Related]
14. A novel series of N-(hexahydro-1,4-diazepin-6-yl) and N-(hexahydroazepin- 3-yl)benzamides with high affinity for 5-HT3 and dopamine D2 receptors.
Hirokawa Y; Morie T; Yamazaki H; Yoshida N; Kato S
Bioorg Med Chem Lett; 1998 Mar; 8(6):619-24. PubMed ID: 9871571
[TBL] [Abstract][Full Text] [Related]
15. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
[TBL] [Abstract][Full Text] [Related]
16. 1,2,5-Thiadiazole derivatives are potent and selective ligands at human 5-HT1A receptors.
Sabb AL; Vogel RL; Kelly MG; Palmer Y; Smith DL; Andree TH; Schechter LE
Bioorg Med Chem Lett; 2001 Apr; 11(8):1069-71. PubMed ID: 11327592
[TBL] [Abstract][Full Text] [Related]
17. Structure-affinity relationship study on N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamides as potent and selective dopamine D(3) receptor ligands.
Leopoldo M; Berardi F; Colabufo NA; De Giorgio P; Lacivita E; Perrone R; Tortorella V
J Med Chem; 2002 Dec; 45(26):5727-35. PubMed ID: 12477356
[TBL] [Abstract][Full Text] [Related]
18. Substitution mode of the amide fragment in some new N-[omega-[4-(2-methoxyphenyl)piperazin-1-yl]alkyl]pyrid-2(1H)-ones and their 5-HT1A/5-HT2A activity.
Paluchowska MH; Bugno R; Charakchieva-Minol S; Bojarski AJ; Wesołowska A
Pol J Pharmacol; 2001; 53(4):369-76. PubMed ID: 11990083
[TBL] [Abstract][Full Text] [Related]
19. Hypothermia reduces the rate of dissociation of specific ligands from dopamine-D2 and 5-hydroxytryptamine1A receptors in the mouse brain in vivo.
Stenfors C; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):479-86. PubMed ID: 11692232
[TBL] [Abstract][Full Text] [Related]
20. N4-unsubstituted N1-arylpiperazines as high-affinity 5-HT1A receptor ligands.
Kuipers W; van Wijngaarden I; Kruse CG; ter Horst-van Amstel M; Tulp MT; IJzerman AP
J Med Chem; 1995 May; 38(11):1942-54. PubMed ID: 7783126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
